首頁 > 市場調查報告書 > 醫療設備

生技設備

寡核苷酸合成設備市場規模、佔有率和成長分析：按類型、技術、外形規格、應用、最終用戶和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

1964197

寡核苷酸合成設備市場規模、佔有率和成長分析：按類型、技術、外形規格、應用、最終用戶和地區分類－2026-2033年產業預測

Oligonucleotide Synthesizer Market Size, Share, and Growth Analysis, By Type, By Technology, By Form Factor, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球寡核苷酸合成設備市場價值為18.2億美元，預計將從2025年的20億美元成長到2033年的43.2億美元。預測期（2026-2033年）的複合年成長率預計為10.09%。

全球寡核苷酸合成設備市場正快速擴張，其主要驅動力是科學研究、診斷和治療領域對精準核酸工具日益成長的需求。基因編輯、反義療法和mRNA疫苗研發對合成寡核苷酸的需求不斷成長，推動了這一成長。合成寡核苷酸在將分子序列轉化為藥物研發和臨床診斷的可操作解決方案方面發揮著至關重要的作用。自動化和固相化學技術的進步正推動產業朝向分散式桌上型合成系統發展，從而縮短處理時間並降低成本。這項轉變凸顯了對能夠生產高純度、大規模文庫的高通量、可靠合成設備日益成長的需求，並促進了自動化純化和品質監控領域的創新。因此，這一趨勢正在推動設備銷售、服務多元化、策略合作，並創造新的商業性機會。

全球寡核苷酸合成設備市場促進因素

寡核苷酸療法的需求日益成長，推動了合成設備技術的投資，促使製造商提升產能並擴大產品線。可靠且柔軟性的合成平台對於臨床和臨床前研究至關重要，因此增加了設備的採購和升級需求。這種需求的成長迫使供應商專注於最佳化通量、縮短週轉時間和提高可重複性，從而增強研究人員和生物製藥公司的信心。因此，這種互動形成了一個良性循環，透過促進技術的持續應用和技術進步，推動市場持續成長，並加強商業和研究合作。

全球寡核苷酸合成設備市場的限制因素

全球寡核苷酸合成設備市場面臨一個重大障礙：先進合成設備需要高額的初始資本投入。這可能會阻礙小規模實驗室和新興生物技術公司做出此類財務承諾。這項投資往往會與其他關鍵研究項目產生衝突，導致潛在買家推遲採購，轉而選擇外包或使用較舊的技術。因此，製造商難以向注重預算的客戶證明其產品的長期價值，因為這些客戶無法立即看到降低營運成本的好處。這種情況導致資金雄厚的機構主導市場，限制了整體市場成長，並阻礙了創新技術的快速普及。

全球寡核苷酸合成設備市場趨勢

全球寡核苷酸合成設備市場正經歷著由先進自動化和機器人技術應用驅動的顯著成長趨勢。這項技術進步實現了高通量生產和更短的生產週期，使企業能夠最佳化生產流程。投資模組化、軟體驅動的平台能夠提升通訊協定的標準化和可重複性，支援批量規模的擴充性，同時確保產品品質。因此，製造商能夠更好地適應市場需求的波動，並促進與合約開發人員的合作。此外，自動化減少了對熟練人工的依賴，增強了營運的韌性，使專業人員能夠專注於寡核苷酸合成領域的創新發展。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific
Agilent Technologies
Integrated DNA Technologies
Eurofins Genomics
Sigma-Aldrich
Biolegio
GenScript
Fasmac
OligoSupply
Primedice
Twist Bioscience
Synthego
Bioneer
Nanjing GenScript
Vazyme
TriLink BioTechnologies
ChemGenes
LGC Biosearch Technologies
QIAGEN
Merck KGaA

結論與建議

簡介目錄

Product Code: SQMIG35J2200

Global Oligonucleotide Synthesizer Market size was valued at USD 1.82 Billion in 2024 and is poised to grow from USD 2.0 Billion in 2025 to USD 4.32 Billion by 2033, growing at a CAGR of 10.09% during the forecast period (2026-2033).

The global oligonucleotide synthesizer market is expanding rapidly due to an increased need for precise nucleic acid tools used in research, diagnostics, and therapeutics. The demand for synthesized oligos, critical for gene editing, antisense therapies, and mRNA vaccine development, propels this growth as they transform molecular sequences into practical solutions for drug discovery and clinical diagnostics. The industry has evolved towards decentralized benchtop synthesizers thanks to advancements in automation and solid-phase chemistry, resulting in reduced turnaround times and costs. This shift emphasizes the rising need for higher-throughput, reliable synthesizers capable of producing large libraries with high purity, thereby prompting innovation in automated purification and quality monitoring. Consequently, this trend fosters instrument sales, service diversification, and strategic partnerships, leading to new commercial opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oligonucleotide Synthesizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesizer Market Segments Analysis

Global oligonucleotide synthesizer market is segmented by type, technology, form factor, application, end-user and region. Based on type, the market is segmented into Standard Synthesizers, High-Throughput Synthesizers, Custom Synthesizers and Integrated Synthesizers. Based on technology, the market is segmented into Solid-Phase Synthesis, Liquid-Phase Synthesis, Microarray Technology and Polymerase Chain Reaction (PCR)-Based Methods. Based on form factor, the market is segmented into Bench-top Synthesizers, Portable Synthesizers, Modular Synthesizers and Automated Synthesizers. Based on application, the market is segmented into Research & Development, Diagnostic Applications, Therapeutic Applications and Forensic Applications. Based on end-user, the market is segmented into Academic Institutions, Pharmaceutical Companies, Biotechnology Firms and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oligonucleotide Synthesizer Market

The increasing demand for oligonucleotide-based therapeutics has spurred investments in synthesizer technologies, prompting manufacturers to enhance their production capabilities and diversify their product offerings. Reliable and flexible synthesis platforms are essential for clinical and preclinical programs, which fuels the need for purchases and upgrades. This heightened demand compels vendors to focus on optimizing throughput, minimizing turnaround times, and improving reproducibility, thereby instilling confidence in researchers and biopharmaceutical companies. Consequently, this interplay generates a positive feedback loop, promoting ongoing adoption and technological advancements that drive continuous market growth and strengthen commercial and research collaborations.

Restraints in the Global Oligonucleotide Synthesizer Market

The Global Oligonucleotide Synthesizer market faces significant barriers due to the high initial capital investment associated with advanced synthesizers, which can deter smaller laboratories and emerging biotech companies from making such financial commitments. This investment often competes with other critical research priorities, causing potential buyers to delay procurement and opt for outsourcing or older technologies instead. As a result, manufacturers encounter difficulties in demonstrating the long-term value of their products to budget-conscious customers who do not immediately see operational savings. Consequently, this scenario creates a market landscape dominated by well-funded institutions, limiting overall expansion and hindering the rapid adoption of innovative technologies.

Market Trends of the Global Oligonucleotide Synthesizer Market

The Global Oligonucleotide Synthesizer market is experiencing a significant trend driven by the adoption of advanced automation and robotics. This technological evolution facilitates high-throughput manufacturing and shorter cycle times, allowing firms to streamline production processes. Investment in modular, software-driven platforms enhances protocol standardization and reproducibility, supporting scalable batch sizes without compromising quality. Consequently, manufacturers are better equipped to adapt to fluctuating demand and foster collaboration with contract developers. Furthermore, automation reduces reliance on specialized manual labor, thereby bolstering operational resilience and enabling skilled professionals to focus on innovative advancements in oligonucleotide synthesis.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Oligonucleotide Synthesizer Market Size by Type & CAGR (2026-2033)

Market Overview
Standard Synthesizers
High-Throughput Synthesizers
Custom Synthesizers
Integrated Synthesizers

Global Oligonucleotide Synthesizer Market Size by Technology & CAGR (2026-2033)

Market Overview
Solid-Phase Synthesis
Liquid-Phase Synthesis
Microarray Technology
Polymerase Chain Reaction (PCR)-Based Methods

Global Oligonucleotide Synthesizer Market Size by Form Factor & CAGR (2026-2033)

Market Overview
Bench-top Synthesizers
Portable Synthesizers
Modular Synthesizers
Automated Synthesizers

Global Oligonucleotide Synthesizer Market Size by Application & CAGR (2026-2033)

Market Overview
Research & Development
Diagnostic Applications
Therapeutic Applications
Forensic Applications

Global Oligonucleotide Synthesizer Market Size by End-User & CAGR (2026-2033)

Market Overview
Academic Institutions
Pharmaceutical Companies
Biotechnology Firms
Diagnostic Laboratories

Global Oligonucleotide Synthesizer Market Size & CAGR (2026-2033)

North America (Type, Technology, Form Factor, Application, End-User)
- US
- Canada
Europe (Type, Technology, Form Factor, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Technology, Form Factor, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Technology, Form Factor, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Technology, Form Factor, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biolegio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fasmac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OligoSupply
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Primedice
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioneer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanjing GenScript
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vazyme
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriLink BioTechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ChemGenes
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Biosearch Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments